Chemoimmunotherapy-associated CD20 (<i>MS4A1</i>) resistance mutations in Waldenstrom macroglobulinemia: Epitope disruption independent of expression with implications for CD20-directed cellular therapies.

ABSTRACT:

SUBMITTER: Guijosa A 

PROVIDER: S-EPMC13626146 | biostudies-literature | 2026 Oct

REPOSITORIES: biostudies-literature